An innovative strategy harnessing self-activating CAR-NK cells to mitigate TGF-β1-driven immune suppression
Seung Hun Shin(Korea University), Mihue Jang(Kyung Hee University), Young Eun Lee(Korea Institute of Science and Technology), Chae Min Yuk(Korea Advanced Institute of Science and Technology), Song Cheol Kim(Ulsan College), Han‐Na Yoon(Korea Institute of Science and Technology), Ji Hyung Kim(Korea University), Yong Jun Kim(Deccan College Post Graduate and Research Institute), Jun Yop An(Io Therapeutics (United States)), Jin‐Chul Kim(Kangwon National University), Sang Won Yoon(Binghamton University), Minkoo Seo(Catholic University of Korea), Sang Chul Shin(Korea University), Min-Suk Oh(Io Therapeutics (United States))
Cited by 19
Related Papers
Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers
|Proceedings of the National Academy of Sciences|2017|577
A Combination of Molecular Markers and Clinical Features Improve the Classification of Pancreatic Cysts
|Gastroenterology|2015|472
Neoadjuvant FOLFIRINOX in Patients With Borderline Resectable Pancreatic Cancer: A Systematic Review and Patient-Level Meta-Analysis
|JNCI Journal of the National Cancer Institute|2019|299
A 3D-printed local drug delivery patch for pancreatic cancer growth suppression
|Journal of Controlled Release|2016|260